Dublin, May 16, 2017 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition of the "Lyophilization Services for Biopharmaceuticals, 2017-2027" report to their offering.

The Lyophilization Services for Biopharmaceuticals, 2017-2027' report provides an extensive study on the current market landscape of lyophilization services for biopharmaceuticals. The study presents an in-depth analysis of a diverse set of companies that provide such services across different regions worldwide. In fact, we identified close to 90 companies that are actively involved in providing lyophilization services for biopharmaceuticals.

The study features a detailed analysis of the existing size and potential future growth opportunities (2017-2027) in the lyophilization services market for biopharmaceuticals. We have provided insights on the likely regional evolution of the market covering North America, Europe (UK, France, Italy, Spain, Germany and rest of Europe), Asia Pacific (Japan, China, India and South Korea) and rest of the world. In addition, we have provided the likely evolution and a market attractiveness analysis on the basis of the type of containment system (bulk containers, vials, syringes, ampoules and cartridges). In order to account for the uncertainties associated with some of the key parameters and to add robustness to our model, we have presented three different forecast scenarios, depicting conservative, base and optimistic tracks of the market's evolution.

The research, analysis and insights presented in this report are backed by a deep understanding of key insights gathered from both secondary and primary research. Actual figures have been sourced and analyzed from publicly available data. For the purpose of the study, we invited over 80 stakeholders to participate in a survey to solicit their opinions on upcoming opportunities, challenges and likely future trends.

The opinions and insights presented in this study were also influenced by discussions conducted with experts in this field. These included contributions from Steven Nail (Principal Scientist, Baxter BioPharma Solutions), Adam Viverette (Lyophilization Manager, Patheon), Patrick DePalma (Director, CMO Business Development, BioDefense Division, Emergent BioSolutions) and John Shaw (Head of Business Development and Marketing, Vibalogics).

Key Topics Covered:

1. PREFACE
1.1. Scope of the Report
1.2. Research Methodology
1.3. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION TO LYOPHILIZATION
3.1. Chapter Overview
3.2. Lyophilization: Historical Background
3.3. Lyophilization: Underlying Principle
3.4. Lyophilization: Equipment
3.5. Lyophilization: Advantages and Disadvantages
3.6. Lyophilization: Applications

4. LYOPHILIZATION OF BIOPHARMACEUTICALS
4.1. Chapter Overview
4.2. Need for Lyophilization of Biopharmaceuticals
4.3. Lyophilization Process for Biopharmaceuticals
4.4. Lyophilization Cycle Development and Optimization
4.5. Containment Systems Used for the Lyophilization of Biopharmaceuticals

5. COMPETITIVE LANDSCAPE
5.1. Chapter Overview
5.2. Lyophilization Service Providers for Biopharmaceuticals: Overall Landscape
5.3. Lyophilization Service Providers for Biopharmaceuticals: Analysis by Type of Biopharmaceuticals Lyophilized
5.4. Lyophilization Service Provides for Biopharmaceuticals: Analysis by Scale of Operation
5.5. Lyophilization Service Providers for Biopharmaceuticals: Analysis by Containment Systems

6. LYOPHILIZATION SERVICE PROVIDERS FOR BIOPHARMACEUTICALS: NORTH AMERICA
6.1. Chapter Overview
6.2. Anteco Pharma
6.3. Axcellerate Pharma
6.4. Berkshire Sterile Manufacturing
6.5. Emergent BioSolutions
6.6. LSNE Contract Manufacturing
6.7. Lyophilization Technology
6.8. Quality BioResources
6.9. North America: Lyophilization Services Market for Biopharmaceuticals, 2017-2027 (USD Million)

7. LYOPHILIZATION SERVICE PROVIDERS FOR BIOPHARMACEUTICALS: EUROPE
7.1. Chapter Overview
7.2. Amatsigroup
7.3. Biopharma Technology
7.4. Boehringer Ingelheim BioXcellence
7.5. LYOCONTRACT
7.6. Lyofal
7.7. Vetter Pharma
7.8. Europe: Lyophilization Services Market for Biopharmaceuticals, 2017-2027 (USD Million)

8. LYOPHILIZATION SERVICE PROVIDERS FOR BIOPHARMACEUTICALS: ASIA PACIFIC
8.1. Chapter Overview
8.2. BioZed Engineering
8.3. Bovogen Biologics
8.4. CinnaGen
8.5. Mycenax Biotech
8.6. Piramal Pharma Solutions
8.7. Samsung Biologics
8.8. Siam Bioscience
8.9. WuXi AppTec
8.10. Asia Pacific: Lyophilization Services Market for Biopharmaceuticals, 2017-2027 (USD Million)
8.10.1. Asia Pacific Lyophilization Services Market for Biopharmaceuticals: Distribution by Type of Containment System (USD Million)

9. MARKET SIZING AND FORECAST
9.1. Chapter Overview
9.2. Forecast Methodology
9.3. Lyophilization Services Market for Biopharmaceuticals, 2017-2027 (USD Million)
9.4. Lyophilization Services Market for Biopharmaceuticals, 2017-2027: Distribution by Region (USD Million)
9.5. Lyophilization Services Market for Biopharmaceuticals, 2017-2027: Distribution by Type of Containment System (USD Million)

10. BENCHMARK ANALYSIS
10.1. Chapter Overview
10.2. Benchmark Analysis: Methodology
10.3. Benchmark Analysis: Peer Groups

11. LYOPHILIZATION CYCLE DEVELOPMENT AND OPTIMIZATION
11.1. Chapter Overview
11.2. Lyophilization Cycle Development
11.3. Lyophilization Cycle Optimization
11.4. Lyophilization Cycle Development and Optimization: Service Providers
11.5. Lyophilization Cycle Development and Optimization Service Providers: Company Snapshots

12. ALTERNATIVE APPROACHES TO LYOPHILIZATION
12.1. Chapter Overview
12.2. Spray Drying
12.3. Spray Freeze Drying
12.4. Atmospheric Spray Freeze Drying
12.5. Vacuum Foam Drying

13. SURVEY ANALYSIS
13.1. Chapter Overview
13.2. Seniority Level of Respondents
13.3. Type of Biopharmaceuticals Lyophilized
13.4. Type of Containment System
13.5. Scale of Operation
13.6. Lyophilization Cycle Development and Optimization
13.7. Location of Lyophilization Facility
13.8. Likely Market Size

14. CONCLUSION
14.1. In Light of High Costs Associated with Establishing In-house Lyophilization Capabilities, Outsourcing has Emerged as a Convenient Alternative
14.2. Cycle Development and Optimization are Among the Key Lyophilization Processes; a Number of Players Specializing in These Services Have Entered the Market Expanding the Value Chain
14.3. Although Alternative Methods have Gained Attention in Recent Times, Lyophilization will Continue to Play a Pivotal Role
14.4. Fueled by the Growing Pipeline of Biopharmaceuticals, the Market is Likely to Witness Continuous Growth in the Coming Decade

15. INTERVIEW TRANSCRIPTS
15.1. Chapter Overview
15.2. Steven Nail, Principal Scientist, Baxter BioPharma Solutions
15.3. Adam Viverette, Lyophilization Manager, Patheon
15.4. Patrick DePalma, Director, CMO Business Development BioDefense Division, Emergent BioSolutions
15.5. John Shaw, Head of Business Development and Marketing, Vibalogics

Companies Mentioned

- AB BioTechnologies
- Affinity Biologicals
- Affinity Life Sciences
- Ajinomoto
- Albany Molecular Research (AMRI)
- Alcami
- Althea
- Amatsigroup
- Anteco Pharma
- Apexigen
- Aptevo Therapeutics
- AusiaBio
- Avrio Biopharmaceuticals
- Axcellerate Pharma
- Axys-Network
- BSP Pharmaceuticals
- Baccinex
- Baxter BioPharma Solutions
- Bayer Healthcare
- Berkshire Sterile Manufacturing (BSM)
- BioConnection
- BioReliance
- BioTechLogic
- BioTechnique
- BioZed Engineering
- Biocon
- Biopharma Technology
- Bioserv Corporation
- Biotechpharma
- Biovian
- Boehringer Ingelheim BioXcellence
- Bovogen Biologicals
- Bryllan
- Burrard Pharmaceuticals
- CARBOGEN AMCIS
- CEPiA
- CMC Biologics
- Camurus
- Canada Peptide
- Capua BioServices
- Catalent
- Cenexi
- CinnaGen
- Clarity BioSolutions
- Cobra Biologics
- Coldstream Laboratories
- Cook Pharmica
- Corden Pharma
- Coriolis Pharma
- CuriRx
- Dalton Pharma Services
- DavosPharma
- EUCODIS Bioscience
- Emergent BioSolutions
- Engineered Biopharmaceuticals
- Eurogentec
- FUJIFILM Diosynth Biotechnologies
- Famar Health Care Services
- Fedegari Group
- Formurex
- Fresenius Kabi Product Partnering
- Frontage Labs
- GILYOS (GIeseler LYOphilization Solutions)
- GP Pharm
- Gipharma
- GlaxoSmithKline (GSK)
- Goodwin Biotechnology
- Grand River Aseptic Manufacturing (GRAM)
- HALIX
- HTD Biosystems
- Hart Biologicals
- Hovione
- Hycult Biotech
- IDIFARMA
- IDT Biologika
- Infectious Disease Research Institute (IDRI)
- Integrity Bio
- Jubilant HollisterStier
- Jubilant Pharma
- KABS Pharmaceutical Services
- KBI Biopharma
- Kamat Pharmatech
- Kemwell Biopharma
- LEUKOCARE
- LSNE Contract Manufacturing
- LYOCONTRACT
- Legacy BioDesign
- Lonza
- Lyofal
- Lyophilization Technology
- MabPlex
- Markt Technologies
- MassDevelopment
- Medicago
- Micro-sphere
- Miltenyi Biotec
- Mycenax Biotech
- NanoTools
- National Institute of Allergy and Infectious Diseases (NIAID)
- Nitto Avecia Pharma Services
- Nova Laboratories
- OctoPlus
- Oncotec Pharma Produktion
- OsoBio
- PREMAS Biotech
- PYRAMID Laboratories
- PaizaBio
- Particle Sciences
- Patheon
- Pfizer CentreOne
- Pharmagen
- Pharmatek
- Pierre Fabre
- Piramal Pharma Solutions
- Praxair
- Praxis Pharmaceutical
- ProJect Pharmaceutics
- Quality BioResources
- Recipharm
- Rentschler
- SGS Group
- SP Scientific
- SYNERLAB Group
- Samsung Biologics
- Sanofi
- Siam Bioscience
- Singota Solutions
- StemProtein
- Symbiosis Pharmaceutical Services
- SynCo Bio Partners
- Syngene
- The Native Antigen Company (NAC)
- Therapure Biomanufacturing
- Tofflon
- Universal Stabilization Technologies
- Upperton
- Vectura
- Vetter Pharma
- Vibalogics
- VxP Pharma
- Wolfe Laboratories
- WuXi AppTec

For more information about this report visit http://www.researchandmarkets.com/research/46rmjf/lyophilization

CONTACT: Research and Markets
         Laura Wood, Senior Manager
         press@researchandmarkets.com
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
         U.S. Fax: 646-607-1907
         Fax (outside U.S.): +353-1-481-1716
         Related Topics: Biopharmaceuticals